US Pfizer, BioNTech Launch Covid-19 Vaccine Trial for Children Under 12 years of Age

Pfizer has begun testing the corona vaccine for children under 12 years of age. The company hopes that the vaccine will also be accessible for children in the early days of 2022. The vaccine has already come for adults of many companies, including Pfizer, to protect against corona


The first corona virus injection in children in the US. Actually, the Pfizer company has started a trial to make Corona vaccine for children. Under this, the first injection has been applied.

US drugmaker Pfizer has begun testing the CoronaVirus vaccine for children under 12 years of age. The company expects that in early 2022, the coronavirus vaccine will be introduced to children as well. The vaccine has already been opened to adults of many companies, including Pfizer, to protect against the corona epidemic and is being rapidly applied.

Pfizer's spokesperson said that the first volunteers were given the first injection for the initial stage trial on wednesday. In the US, people aged 16 years or above are receiving Pfizer's coronavirus vaccine. In the US,66 million people have been vaccinated with the Corona virus till Wednesday morning. A similar trial was commenced by the Moderna company last week to vaccinate the coronavirus vaccine in children up to 6 months old.

Only Pfizer vaccine is being administered in the United States for children 16–17 years old. Besides, it has been sanctioned to apply Modernas coronavirus vaccine to people 18 years or above. No corona vaccine has been permitted for young children yet. Pfizer has made a goal to give its twice-daily vaccine to children in 3 different doses.

A total of 144 children are taking part in this phase 1/2 trial. Subsequently, the company plans to vaccinate 4500 children in the subsequent trial phase. During this time, the company will test the safety of children, vaccine tolerance and vaccine-borne immunity. The company is hopeful that this will be completed in the first 6 months of the year 2021.

 

The Brief. Sign up to receive the top stories you need to know right now.